<?xml version="1.0" encoding="UTF-8"?>
<ref id="B237">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vigil</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Estelles</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kauvar</surname>
    <given-names>L. M.</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>S. K.</given-names>
   </name>
   <name>
    <surname>Tripp</surname>
    <given-names>R. A.</given-names>
   </name>
   <name>
    <surname>Wittekind</surname>
    <given-names>M.</given-names>
   </name>
  </person-group> (
  <year>2018</year>). 
  <article-title>Native human monoclonal antibodies with potent cross-lineage neutralization of influenza B viruses</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <volume>62</volume>:
  <fpage>e02269</fpage>â€“
  <lpage>e02217</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.02269-17</pub-id>
  <?supplied-pmid 29507069?>
  <pub-id pub-id-type="pmid">29507069</pub-id>
 </mixed-citation>
</ref>
